<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rpmj</journal-id><journal-title-group><journal-title xml:lang="ru">Research'n Practical Medicine Journal</journal-title><trans-title-group xml:lang="en"><trans-title>Research and Practical Medicine Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2410-1893</issn><publisher><publisher-name>"QUASAR", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17709/2410-1893-2022-9-4-1</article-id><article-id custom-type="elpub" pub-id-type="custom">rpmj-786</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи. Онкология, лучевая терапия</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Articles. Оncology</subject></subj-group></article-categories><title-group><article-title>Сравнительная оценка результатов выполненных D2 и D3 лимфодиссекций в хирургии рака ободочной кишки</article-title><trans-title-group xml:lang="en"><trans-title>Comparative assessment of results of D2 and D3 lymph node dissections in term of colon cancer surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3061-6108</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кит</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kit</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кит Олег Иванович – академик РАН, доктор медицинских наук, профессор, генеральный директор</p><p>Ростов-на-Дону</p><p>SPIN: 1728-0329,</p><p>AuthorID: 343182,</p><p>ResearcherID: U-2241-2017,</p><p>Scopus Author ID: 55994103100</p></bio><bio xml:lang="en"><p>Oleg I. Kit – academician of the Russian Academy of Sciences, Dr. Sci. (Med.), professor, general director</p><p>Rostov-on-Don</p><p>SPIN: 1728-0329,</p><p>AuthorID: 343182,</p><p>ResearcherID: U-2241-2017,</p><p>Scopus Author ID: 55994103100</p></bio><email xlink:type="simple">rnioi@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3561-098X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дженкова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhenkova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дженкова Елена Алексеевна – доктор медицинских наук, доцент, ученый секретарь</p><p>Ростов-на-Дону</p><p>SPIN: 6206-6222,</p><p>AuthorID: 697354,</p><p>ResearcherID: K-9622-2014,</p><p>Scopus Author ID: 6507889745</p></bio><bio xml:lang="en"><p>Elena A. Dzhenkova – Dr. Sci. (Biol.), academic secretary</p><p>Rostov-on-Don</p><p>SPIN: 6206-6222,</p><p>AuthorID: 697354,</p><p>ResearcherID: K-9622-2014,</p><p>Scopus Author ID: 6507889745</p></bio><email xlink:type="simple">rnioi@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0328-9714</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мирзоян</surname><given-names>Э. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mirzoyan</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мирзоян Эллада Арменовна – аспирант</p><p>344037, г. Ростов-на-Дону, ул. 14-я линия, д. 63</p><p>SPIN: 2506-8605,</p><p>AuthorID: 1002948,</p><p>ResearcherID: AAZ-2780-2021,</p><p>Scopus Author ID: 57221118516</p></bio><bio xml:lang="en"><p>Ellada A. Mirzoyan – PhD student</p><p>63 14 line str., Rostov-on-Don 344037</p><p>AuthorID: 1002948,</p><p>ResearcherID: AAZ-2780-2021,</p><p>Scopus Author ID: 57221118516</p></bio><email xlink:type="simple">ellada.mirzoyan@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1957-7363</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геворкян</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gevorkyan</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Геворкян Юрий Артушевич – доктор медицинских наук, профессор, заведующий отделением абдоминальной онкологии № 2</p><p>Ростов-на-Дону</p><p>SPIN: 8643-2348,</p><p>AuthorID: 711165</p></bio><bio xml:lang="en"><p>Yuriy A. Gevorkyan – Dr. Sci. (Med.), professor, head of the department of abdominal oncology No. 2</p><p>Rostov-on-Don</p><p>SPIN: 8643-2348,</p><p>AuthorID: 711165</p></bio><email xlink:type="simple">ellada.mirzoyan@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9749-709X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесников</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikov</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесников Евгений Николаевич – доктор медицинских наук, заведующий отделением абдоминальной онкологии № 1 с группой рентгенэндоваскулярных методов диагностики и лечения</p><p>Ростов-на-Дону</p><p>SPIN: 8434-6494,</p><p>AuthorID: 347457</p></bio><bio xml:lang="en"><p>Evgeniy N. Kolesnikov – Dr. Sci. (Med.), head of department of abdominal oncology No. 1 with a group of roentgen endovascular methods of diagnostics and treatment</p><p>Rostov-on-Don</p><p>SPIN: 8434-6494,</p><p>AuthorID: 347457</p></bio><email xlink:type="simple">ellada.mirzoyan@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3998-8004</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Снежко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Snezhko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Снежко Александр Владимирович – доктор медицинских наук, хирург отделения абдоминальной онкологии № 1</p><p>Ростов-на-Дону</p><p>SPIN: 2913-3744,</p><p>AuthorID: 439135,</p><p>Scopus Author ID: 6701854863</p></bio><bio xml:lang="en"><p>Aleksandr V. Snezhko – Dr. Sci. (Med.), MD, surgeon at the abdominal oncology department No. 1</p><p>Rostov-on-Don</p><p>SPIN: 2913-3744,</p><p>AuthorID: 439135,</p><p>Scopus Author ID: 6701854863</p></bio><email xlink:type="simple">ellada.mirzoyan@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ онкологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ "НМИЦ онкологии" Минздрава России г. Ростов-на-Дону</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2022</year></pub-date><volume>9</volume><issue>4</issue><fpage>10</fpage><lpage>17</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кит О.И., Дженкова Е.А., Мирзоян Э.А., Геворкян Ю.А., Колесников Е.Н., Снежко А.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Кит О.И., Дженкова Е.А., Мирзоян Э.А., Геворкян Ю.А., Колесников Е.Н., Снежко А.В.</copyright-holder><copyright-holder xml:lang="en">Kit O.I., Dzhenkova E.A., Mirzoyan E.A., Gevorkyan Y.A., Kolesnikov E.N., Snezhko A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpmj.ru/rpmj/article/view/786">https://www.rpmj.ru/rpmj/article/view/786</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Провести оценку общей выживаемости больных после выполненных стандартной и расширенной лимфодиссекций (D2- и D3‑лимфодиссекций соответственно) при раке ободочной кишки (РОК) и оценить частоту послеоперационных осложнений и динамику послеоперационного восстановления.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включены 50 больных РОК в возрасте от 39 до 84 лет.</p></sec><sec><title>Результаты</title><p>Результаты. Для сравнительной оценки общей выживаемости, частоты послеоперационных осложнений и динамики послеоперационного восстановления пациенты были разделены на 2 группы в зависимости от объема лимфодиссекции. 1‑ая группа – 23 пациента (46 %), которым была выполнена D2 лимфодиссекция, 2‑ая – 27 (54 %), которым были выполнены оперативные вмешательства с D3 лимфодиссекцией. В раннем послеоперационном периоде у 8 (16 %) больных развились осложнения. По классификации Clavien-Dindo у 5 пациентов из 1‑ой группы возникли хирургические осложнения I степени, у одного – III b степени. У 2 пациентов из 2‑ой группы– осложнения III b степени. Достоверных различий между группами по времени появления перистальтики, газов и стула, начало приема жидкостей и пищи не обнаружено. Выявлено достоверное увеличение продолжительности пребывания после выявленных открытых операций по сравнению с группой пациентов, у которых использовался лапароскопический доступ. При оценки общей выживаемости в двух сравниваемых группах не было выявлено статистически значимых различий (p = 0,918).</p></sec><sec><title>Заключение</title><p>Заключение. Таким образом, частота послеоперационных осложнений, требующих повторного хирургического вмешательства, после выполнения D3 лимфодиссекции была сопоставима со сравниваемой группой. Выполнение хирургического вмешательства с D3 лимфодиссекцией не повлияло на динамику послеоперационного восстановления и на общую выживаемость пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of the study</title><p>Purpose of the study. Was to evaluate overall survival of CC patients after D2 and D3 lymph node dissections and assess the frequency of postoperative complications and dynamics of postoperative recovery.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study included 50 CC patients aged 39–84 years.</p></sec><sec><title>Results</title><p>Results.  The comparative assessment of the overall survival, frequency of postoperative complications and dynamics of postoperative recovery was performed in patients divided into 2 groups depending on the lymph node dissection extent. Group 1 included 23 patients (46 %) with D2 lymph node dissection, group 2–27 patients (54 %) with D3 lymph node dissection. 8 (16 %) patients developed complications in the early postoperative period. Patients in group 1 had grade I (5 patients) and grade IIIb (1 patient) surgical complications, according to the Clavien-Dindo classification. 2 patients in group 2 developed grade III b complications. No significant differences were found between groups in peristalsis, gases and bowel movement, starting eating and drinking. A significant increase in the number of postoperative bed-days was observed in patients who underwent open surgery, compared with the group with laparoscopic access. No statistically significant difference was found in the overall survival in patients of the two groups (p = 0.918).</p></sec><sec><title>Conclusion</title><p>Conclusion. The rates of postoperative complications that required repeated surgery were comparable between the groups with D2 and D3 lymph node dissections. D3 lymph node dissection did not affect the dynamics of postoperative recovery and the overall survival of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>колоректальный рак</kwd><kwd>рак ободочной кишки</kwd><kwd>D2/D3 лимфодиссекция</kwd><kwd>послеоперационное восстановление</kwd><kwd>общая выживаемость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>colorectal cancer</kwd><kwd>colon cancer</kwd><kwd>D2/D3 lymph node dissection</kwd><kwd>postoperative recovery</kwd><kwd>overall survival</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000- 2014). J Clin Med. 2018 Jan 30;7(2):22. https://doi.org/10.3390/jcm7020022</mixed-citation><mixed-citation xml:lang="en">Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000- 2014). J Clin Med. 2018 Jan 30;7(2):22. https://doi.org/10.3390/jcm7020022</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. М.: МНИОИ им. П. А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021, 252 с.</mixed-citation><mixed-citation xml:lang="en">Malignant neoplasms in Russia in 2020 (morbidity and mortality). Edited by A. D. Kaprin, V. V. Starinsky, A. O. Shakhzadova. Moscow: P. A. Herzen MNIOI – Branch of the National Medical Research Radiological Center, 2021, 252 p.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Осомбаев М. Ш., Джекшенов М. Д., Сатыбалдиев О. А., Абдрасулов К. Д., Макимбетов Э. К., Кузикеев М. А. Эпидемиология колоректального рака. Научное обозрение. Медицинские науки. 2021;1:37–42. https://doi.org/10.17513/srms.1169</mixed-citation><mixed-citation xml:lang="en">Osombaev MSh, Dzhekshenov MD, Satybaldiev OA, Abdrasulov KD, Makimbetov EK, Kuzikeev MA. Epidemiology of colorectal cancer. Scientific Review. Medical Sciences. 2021;1:37–42. (In Russ.). https://doi.org/10.17513/srms.1169</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Karachun A, Panaiotti L, Chernikovskiy I, Achkasov S, Gevorkyan Y, Savanovich N, et al. Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial). Br J Surg. 2020 Apr;107(5):499– 508. https://doi.org/10.1002/bjs.11387</mixed-citation><mixed-citation xml:lang="en">Karachun A, Panaiotti L, Chernikovskiy I, Achkasov S, Gevorkyan Y, Savanovich N, et al. Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial). Br J Surg. 2020 Apr;107(5):499– 508. https://doi.org/10.1002/bjs.11387</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Карачун А. М., Панайотти Л. Л., Петров А. С. Выбор оптимального объема лимфодиссекции в хирургическом лечении рака ободочной кишки: протокол клинического исследования. Тазовая хирургия и онкология. 2017;5(2):11–19. https://doi.org/10.17650/2220-3478-2017-7-2-11-19</mixed-citation><mixed-citation xml:lang="en">Karachun AM, Panayotti LL, Petrov AS. The choice of optimal lymph node dissection extent in surgical treatment for colon cancer: protocol the clinical trial. Pelvic Surgery and Oncology. 2017;7(2):11–19. (In Russ.). https://doi.org/10.17650/2220-3478-2017-7-2-11-19</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Surg. 1983 Nov;13(6):574–598. https://doi.org/10.1007/bf02469506</mixed-citation><mixed-citation xml:lang="en">General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Surg. 1983 Nov;13(6):574–598. https://doi.org/10.1007/bf02469506</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015 Apr;20(2):207–239. https://doi.org/10.1007/s10147-015-0801-z</mixed-citation><mixed-citation xml:lang="en">Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015 Apr;20(2):207–239. https://doi.org/10.1007/s10147-015-0801-z</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000 Jul 8;356(9224):93–96. https://doi.org/10.1016/s0140-6736(00)02469-7</mixed-citation><mixed-citation xml:lang="en">Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000 Jul 8;356(9224):93–96. https://doi.org/10.1016/s0140-6736(00)02469-7</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sondenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, Kessler H, et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference. Int J Colorectal Dis. 2014 Apr;29(4):419–428. https://doi.org/10.1007/s00384-013-1818-2</mixed-citation><mixed-citation xml:lang="en">Sondenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, Kessler H, et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference. Int J Colorectal Dis. 2014 Apr;29(4):419–428. https://doi.org/10.1007/s00384-013-1818-2</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, et al. The prognostic significance of total lymph node harvest in patients with T2- 4N0M0 colorectal cancer. J Gastrointest Surg. 2007 May;11(5):660–665. https://doi.org/10.1007/s11605-007-0119-x</mixed-citation><mixed-citation xml:lang="en">Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, et al. The prognostic significance of total lymph node harvest in patients with T2- 4N0M0 colorectal cancer. J Gastrointest Surg. 2007 May;11(5):660–665. https://doi.org/10.1007/s11605-007-0119-x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Willaert W, Ceelen W. Extent of surgery in cancer of the colon: is more better? World J Gastroenterol. 2015 Jan 7;21(1):132–138. https://doi.org/10.3748/wjg.v21.i1.132</mixed-citation><mixed-citation xml:lang="en">Willaert W, Ceelen W. Extent of surgery in cancer of the colon: is more better? World J Gastroenterol. 2015 Jan 7;21(1):132–138. https://doi.org/10.3748/wjg.v21.i1.132</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Willaert W, Mareel M, Van De Putte D, Van Nieuwenhove Y, Pattyn P, Ceelen W. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon. Cancer Treat Rev. 2014 Apr;40(3):405–413. https://doi.org/10.1016/j.ctrv.2013.09.013</mixed-citation><mixed-citation xml:lang="en">Willaert W, Mareel M, Van De Putte D, Van Nieuwenhove Y, Pattyn P, Ceelen W. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon. Cancer Treat Rev. 2014 Apr;40(3):405–413. https://doi.org/10.1016/j.ctrv.2013.09.013</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009 May;11(4):354–364. https://doi.org/10.1111/j.1463-1318.2008.01735.x</mixed-citation><mixed-citation xml:lang="en">Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009 May;11(4):354–364. https://doi.org/10.1111/j.1463-1318.2008.01735.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bertelsen CA, Neuenschwander AU, Jansen JE, Wilhelmsen M, Kirkegaard-Klitbo A, Tenma JR, et al. Danish Colorectal Cancer Group. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015 Feb;16(2):161–168. https://doi.org/10.1016/s1470-2045(14)71168-4</mixed-citation><mixed-citation xml:lang="en">Bertelsen CA, Neuenschwander AU, Jansen JE, Wilhelmsen M, Kirkegaard-Klitbo A, Tenma JR, et al. Danish Colorectal Cancer Group. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015 Feb;16(2):161–168. https://doi.org/10.1016/s1470-2045(14)71168-4</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum. 2003 Jul;46(7):860–866. https://doi.org/10.1007/s10350-004-6673-3</mixed-citation><mixed-citation xml:lang="en">Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum. 2003 Jul;46(7):860–866. https://doi.org/10.1007/s10350-004-6673-3</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007 Mar 21;99(6):433–441. https://doi.org/10.1093/jnci/djk092</mixed-citation><mixed-citation xml:lang="en">Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007 Mar 21;99(6):433–441. https://doi.org/10.1093/jnci/djk092</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Eiholm S, Ovesen H. Total mesocolic excision versus traditional resection in right-sided colon cancer - method and increased lymph node harvest. Dan Med Bull. 2010 Dec;57(12):A4224.</mixed-citation><mixed-citation xml:lang="en">Eiholm S, Ovesen H. Total mesocolic excision versus traditional resection in right-sided colon cancer - method and increased lymph node harvest. Dan Med Bull. 2010 Dec;57(12):A4224.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Galizia G, Lieto E, De Vita F, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, Castellano P, Napolitano V, Orditura M. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study. Int J Colorectal Dis. 2014 Jan;29(1):89–97. https://doi.org/10.1007/s00384-013-1766-x</mixed-citation><mixed-citation xml:lang="en">Galizia G, Lieto E, De Vita F, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, Castellano P, Napolitano V, Orditura M. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study. Int J Colorectal Dis. 2014 Jan;29(1):89–97. https://doi.org/10.1007/s00384-013-1766-x</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, et al. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Oncol Rep. 2003 Jul-Aug;10(4):927–934.</mixed-citation><mixed-citation xml:lang="en">Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, et al. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Oncol Rep. 2003 Jul-Aug;10(4):927–934.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Siani LM, Pulica C. Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: Long-term oncologic outcome between mesocolic and non-mesocolic planes of surgery. Scand J Surg. 2015 Dec;104(4):219–226. https://doi.org/10.1177/1457496914557017</mixed-citation><mixed-citation xml:lang="en">Siani LM, Pulica C. Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: Long-term oncologic outcome between mesocolic and non-mesocolic planes of surgery. Scand J Surg. 2015 Dec;104(4):219–226. https://doi.org/10.1177/1457496914557017</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Storli KE, Søndenaa K, Furnes B, Nesvik I, Gudlaugsson E, Bukholm I, Eide GE. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II. Tech Coloproctol. 2014 Jun;18(6):557–564. https://doi.org/10.1007/s10151-013-1100-1</mixed-citation><mixed-citation xml:lang="en">Storli KE, Søndenaa K, Furnes B, Nesvik I, Gudlaugsson E, Bukholm I, Eide GE. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II. Tech Coloproctol. 2014 Jun;18(6):557–564. https://doi.org/10.1007/s10151-013-1100-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tagliacozzo S, Accordino M, Tocchi A. Extended lymphadenectomy during resection of cancer of the right colon. Eur J Surg. 1994 Mar;160(3):179–181.</mixed-citation><mixed-citation xml:lang="en">Tagliacozzo S, Accordino M, Tocchi A. Extended lymphadenectomy during resection of cancer of the right colon. Eur J Surg. 1994 Mar;160(3):179–181.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kotake K, Mizuguchi T, Moritani K, Wada O, Ozawa H, Oki I, Sugihara K. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis. 2014 Jul;29(7):847–852. https://doi.org/10.1007/s00384-014-1885-z</mixed-citation><mixed-citation xml:lang="en">Kotake K, Mizuguchi T, Moritani K, Wada O, Ozawa H, Oki I, Sugihara K. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis. 2014 Jul;29(7):847–852. https://doi.org/10.1007/s00384-014-1885-z</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
